Preclinical studies demonstrate that cannabidiol (CBD) elicits an antinociceptive response in animal models of neuropathic pain; in humans, limited data are available to support such analgesic effects. Few studies have examined CBD’s analgesic effects when administered without other compounds, and little is known regarding dose-dependent effects in non-cannabis users.
The post The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans appeared first on Society of Cannabis Clinicians.